Idrx Launches With $122 Million Series A Financing To Treat Cancer With Purpose-Built Precision Combination Therapies
Amount Raised
$122 Million
Round Type
Series A
PlymouthBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
IDRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment with purpose-built precision combination therapies, launched today with a $122 million oversubscribed Series A financing. The financing was led by Andreessen Horowitz (a16z) and Casdin Capital, with participation from Nextech Invest, Forge Life Science Partners and other undisclosed investors. Inspired by a few curative combination regimens in cancer and the successful drug cocktails engineered in other disease areas such as cystic fibrosis and antivirals, IDRx was incubated by Borisy Labs to address the limitations of today’s precision cancer medicines with highly selective, purposely designed drug combinations to help more patients achieve prolonged, durable responses to therapy earlier in the course of their disease.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as IDRx that raised within 45 days of this round, from Fundz verified event records.
- SpringWorks raised $225M (Post-IPO Equity) on September 7, 2022.
- Abivax raised $49M (Funding Round) on September 2, 2022.
- LumaBridge raised an undisclosed amount (Private Equity) on August 23, 2022.
- Avelos Therapeutics raised an undisclosed amount (Series A) on August 22, 2022.
- Biofrontera raised $7.1M on July 27, 2022.
- Carver raised an undisclosed amount (Seed) on September 15, 2022.
Who to call at IDRx, and when
A new round usually means IDRx is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day IDRx raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at IDRx, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at IDRx. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment IDRx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansIDRx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.